Access to influenza vaccine in East Harlem and the Bronx during a national vaccine shortage

Journal of Community Health

Volumn 32, Issue 3, 2007, Pages 195-202

  Ompad, Danielle C ^a   Galea, Sandro ^a,b,c   Blaney, Shannon ^a   Coady, Micaela H ^a   Sisco, Sarah ^a   Glidden, Kathryn ^a   Vlahov, David ^a,c  

^a NEW YORK ACADEMY OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Department of Medicine   (United States)

Author keywords

Community based participatory research; Health disparities; Influenza; Vaccination; Vaccine shortage

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG MANUFACTURE; FEMALE; GOVERNMENT; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HIGH RISK POPULATION; HUMAN; INFLUENZA; MALE; RACE DIFFERENCE; SOCIOECONOMICS; UNITED STATES; VACCINATION;

ADULT; AGED; CONSUMER PARTICIPATION; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA VACCINES; MALE; MASS MEDIA; MIDDLE AGED; NEW YORK CITY; POVERTY AREAS; VACCINATION; VULNERABLE POPULATIONS;

EID: 34247847763     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10900-006-9043-3     Document Type: Article

References (13)

1. Miniño AM, Heron MP, Smith BL. Deaths: Preliminary data for 2004. Natl Vital Stat Rep 2006; 54:1-50.
2. Advisory Committee on Immunization Practices. Prevention and control of influenza. MMWR Morb Mortal Wkly Rep 2002; 51:1-31.
3. Pollack A. U.S. Will Miss Half Its Supply Of Flu Vaccine. New York TImes 2004 Oct 6; A1, A20.
4. Estimated influenza vaccination coverage among adults and children-United States, September 1, 2004-January 31, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:304-307.
5. Marin MG, Johanson WG Jr., Salas-Lopez D. Influenza vaccination among minority populations in the United States. Prev Med 2002; 34:235-241.
6. Petersen RL, Saag K, Wallace RB, Doebbeling BN. Influenza and pneumococcal vaccine receipt in older persons with chronic disease: a population-based study. Med Care 1999; 37:502-509.
7. Bryant WK, Ompad DC, Sisco S, Blaney S, Glidden K, Phillips E, et al. Determinants of influenza vaccination in hard-to-reach urban populations. Prev Med 2006; 43:60-70.
8. Muhib FB, Lin LS, Stueve A, Miller RL, Ford WL, Johnson WD, et al. A venue-based method for sampling hard-to-reach populations. Public Health Rep 2001; 116(Suppl 1), 216-222.
9. Santibanez TA, Nowalk MP, Zimmerman RK, Bruehlman RD. Effects of the year 2000 influenza vaccine delay on elderly patients' attitudes and behaviors. Prev Med 2003; 37:417-423.
10. Experiences with obtaining influenza vaccination among persons in priority groups during a vaccine shortage-United States, October-November, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:1153-1155.
11. Ompad DC, Galea S, Vlahov D. Distribution of influenza vaccine to high-risk groups. Epidemiol Rev 2006; 28:54-70.
12. Offit PA. Why are pharmaceutical companies gradually abandoning vaccines? Health Aff (Millwood) 2005; 24:622-630.
13. Wynia MK. Markets and public health: pushing and pulling vaccines into production. Am J Bioeth 2006; 6:3-6.